Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CHNA vs. ETIHX: which is better?

Bottom line

CHNA vs ETIHX: the short answer

CHNA (Loncar China BioPharma ETF) and ETIHX (Eventide Healthcare & Life Sciences Fund) are both etfs.

Updated Nov 19, 2026

CHNA vs ETIHX side by side

CHNAETIHX
TypeETFMutual fund
Fund familyGrayscaleMutual
CategoryHealth Care SectorHealth Care Sector
Expense ratio—1.29%
Annual cost per $10k—$129
10-yr cost on $10k (prospectus)—$1,556
Max front loadNone0%
12b-1 fee—0%
1-yr return—+56.7%
5-yr return (annualized)—+1.0%
10-yr return (annualized)—+10.8%
Best quarter—+46.4%
Worst quarter—−24.4%
Net assets (fund)—$1.8B
Number of holdings—93
Portfolio turnover—87%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

CHNA and ETIHX share none of their top holdings.

CHNA top 10

    ETIHX top 10

    1. Guardant Health Inc — 5.37%
    2. US Bank Mmda — 3.75%
    3. Mirum Pharmaceuticals Inc — 3.47%
    4. Kymera Therapeutics Inc — 3.22%
    5. Abivax Sa — 2.94%
    6. BeLite Bio Inc — 2.83%
    7. Trevi Therapeutics Inc — 2.77%
    8. Mbx Biosciences Inc — 2.70%
    9. Vaxcyte Inc — 2.69%
    10. Cytokinetics Inc — 2.69%

    FAQ

    What is the difference between CHNA and ETIHX?
    CHNA (Loncar China BioPharma ETF) and ETIHX (Eventide Healthcare & Life Sciences Fund) are both etfs.
    Should I own both CHNA and ETIHX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.